Concurrent hormone therapy may augment the cardiometabolic benefits of tirzepatide, including improved blood pressure and lipid profiles.

Girls with central precocious puberty (CPP) and premature thelarche exhibit distinct DXA-based body composition and bone density patterns.

Wildfire smoke exposure during pregnancy may increase the risk for autism spectrum disorder (ASD), according to a new study.

GLP-1RA therapy vs metformin may offer time-dependent neuroprotection against Parkinson disease among patients with type 2 diabetes.

Patients undergoing gender-affirming vaginoplasty experience worsening of OAB with respect to their health-related quality of life (HRQoL).

The US Food and Drug Administration (FDA) is relaxing a long-standing drug approval requirement for common diseases.

Nutritional interventions, particularly supplements, are associated with significant improvements in anxiety among patients with T2D.

Phase 3 PEACE trial data support the accelerated approval of Loargys for the treatment of arginase 1 deficiency in pediatric and adult patients.

FDA approves swallowable Allurion Gastric Balloon for weight loss in adults with obesity who failed prior lifestyle programs.

The risk for nonscarring hair loss (NSHL) is increased in association with glucagon-like peptide-1 receptor agonist (GLP-1 RA) use.

SSRI medication use during pregnancy may increase the risk for GD and some poor newborn outcomes, but may protect against adverse outcomes.

Significant diet-induced weight loss led to sustained declines in bone mineral content and proportional lean mass loss.